XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,254,559 | -11.3% | 212,370 | -0.1% | 0.00% | – |
Q2 2023 | $8,183,175 | +10.2% | 212,550 | +2.5% | 0.00% | – |
Q1 2023 | $7,424,700 | -52.3% | 207,456 | -47.5% | 0.00% | – |
Q4 2022 | $15,569,802 | +153.2% | 394,872 | +131.8% | 0.00% | – |
Q3 2022 | $6,150,000 | +2.5% | 170,371 | -13.6% | 0.00% | – |
Q2 2022 | $5,999,000 | +14.1% | 197,221 | +14.7% | 0.00% | – |
Q1 2022 | $5,258,000 | +4.4% | 171,987 | +6.7% | 0.00% | – |
Q4 2021 | $5,037,000 | +123.6% | 161,249 | +9.4% | 0.00% | – |
Q3 2021 | $2,253,000 | -7.4% | 147,447 | +12.9% | 0.00% | – |
Q2 2021 | $2,432,000 | +38.5% | 130,595 | +33.1% | 0.00% | – |
Q1 2021 | $1,756,000 | +22.3% | 98,088 | +5.0% | 0.00% | – |
Q4 2020 | $1,436,000 | +44.9% | 93,386 | +4.3% | 0.00% | – |
Q3 2020 | $991,000 | -8.8% | 89,547 | +3.3% | 0.00% | – |
Q2 2020 | $1,087,000 | +405.6% | 86,664 | +356.7% | 0.00% | – |
Q1 2020 | $215,000 | -19.5% | 18,978 | -6.8% | 0.00% | – |
Q4 2019 | $267,000 | +43.5% | 20,360 | -1.5% | 0.00% | – |
Q3 2019 | $186,000 | -8.8% | 20,664 | 0.0% | 0.00% | – |
Q2 2019 | $204,000 | -2.9% | 20,664 | 0.0% | 0.00% | – |
Q1 2019 | $210,000 | +56.7% | 20,664 | -2.9% | 0.00% | – |
Q4 2018 | $134,000 | -47.9% | 21,288 | +9.2% | 0.00% | – |
Q3 2018 | $257,000 | – | 19,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |